IPR# 126062700 / SOQ# 22601586 / Pharmaceutical item / SKA

Dubai Academic Health Corporation

Published: Jun 18, 2026

Updated: Jun 25, 2026

Source: dubai_esupply

This tender has expired

The submission deadline for this tender has passed. It is no longer accepting bids.

Browse open Health & Medical tenders in United Arab Emirates

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in United Arab Emirates, Middle East & North Africa, this opportunity is open to firms and consortiums. Proposals must be submitted before June 25, 2026.

Published through Dubai eSupply, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender concerns the procurement of a specific pharmaceutical item, to be supplied within the United Arab Emirates. The tender is being advertised on the dubai_esupply platform, a common channel for government and institutional procurements in the region. The contracting authority is expected to be a public sector organization or a large healthcare institution. Essential requirements for participating bidders will include the ability to supply the specified pharmaceutical product according to precise technical and quality standards. This typically involves demonstrating compliance with international pharmaceutical quality regulations, such as GMP, and meeting the specific registration and approval requirements of the UAE Ministry of Health and Prevention. Bidders will need to provide comprehensive documentation regarding their company's profile, manufacturing facilities, product details, and quality assurance systems. The tender will likely detail the required quantities, delivery timelines, and the specific points of delivery within the UAE. Experience in supplying pharmaceuticals to the MENA region and a demonstrated capacity for efficient logistics and cold chain management, if applicable, will be advantageous for potential suppliers.

Data provenance

This notice is sourced from Dubai eSupply and was originally published on June 18, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dubai Academic Health Corporation

Dubai Academic Health Corporation has issued 805 procurement notices on BidsFactory, including 96 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, Governance & Public Administration, and General Supplies & Services. All notices are published for United Arab Emirates. Notices are distributed via Dubai eSupply. Most recent publication: June 18, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in United Arab Emirates. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Dubai eSupply to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is June 25, 2026. Proposals must be received by the contracting authority before that date.

Who is the contracting authority?

This notice was issued by Dubai Academic Health Corporation in United Arab Emirates. The authority is responsible for evaluating bids, awarding the contract, and managing performance.